Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
52 /100
HIGH RISK
Score updated Oct 13, 2026

ALLO — Allogene Therapeutics, Inc. Dilution Risk Tracker

Track ALLO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ALLO — Get alerts when the score changes →

As of October 13, 2026, Allogene Therapeutics, Inc. (ALLO) has a DilutionWatch DilutionScore of 52/100, rated HIGH dilution risk. Allogene Therapeutics, Inc. has a market capitalization of $483.69M, 345.49M shares outstanding, 208 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $500.00M, ATM program capacity of $135.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
25
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 23%
💰 Capital Raise model 38%
• Active shelf registration ($500M, 103% of market cap)
• Active ATM program with $135M remaining capacity
🔄 Reverse Split model est. 15%
• 52-week low $0.98 has breached $1
🔔 Track ALLO — Get forecast alerts →

Market Data

Market Cap$483.69M
Shares Outstanding345.49M
Float269.64M
Cash$322.61M
Debt$81.05M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore52/100DilutionWatch score record
Shares Outstanding345.49MVerified float table or market cache
Public Float269.64MVerified float table or market cache
Market Cap$483.69MMarket data cache
Cash Runway20.6 monthsDilutionWatch score inputs
Shelf Capacity$500.00MSEC-derived dilution fields
ATM Capacity$135.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 1, EFFECT 1, S-3 1, SC 13D/A 1, SC 13G/A 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 26.1% shares (2026Q1 vs prior)
208 institutional holders · 207.61M shares
#1 Pfizer Inc 22.03M shares
#2 BlackRock, Inc. 19.09M shares
#3 TPG GP A, LLC 18.72M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest55.61M
Days to Cover9.0
% of Float20.6%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-02-25
SC 13D/A BENEFICIAL OWNERSHIP 2026-09-30
4 INSIDER TRANSACTION 2026-08-25
EFFECT EFFECT 2026-08-20
SC 13G/A BENEFICIAL OWNERSHIP 2026-08-14
Full SEC filing analysis available with free account →

Recent News

Factual ALLO Dilution Snapshot

Allogene Therapeutics, Inc. (ALLO) has a DilutionScore of 52/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ALLO's DilutionScore is currently 52/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 51/100 (High risk).

Period Score Risk Level Duration
Oct 13, 202652/100HIGH1 day
Aug 22 – Oct 12, 202651/100HIGH52 days
Aug 14 – Aug 21, 202637/100MEDIUM7 days
Jul 16 – Aug 13, 202634/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ALLO shares outstanding have increased 53.5% from 224.73M (Mar 2026) to 345.02M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 17, 2026345.02M269.64M▼ 0.08%
May 16, 2026345.02M269.85M▲ 41.71%
Apr 27, 2026343.98M190.42M▼ 6.54%
Apr 19, 2026331.28M203.75M▲ 8.79%
Apr 07, 2026243.78M187.29M▼ 0.06%
Mar 17, 2026224.73M187.40M▲ 10.57%
Mar 14, 2026224.73M169.48M▲ 8.48%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ALLO Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ALLO files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ALLO — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ALLO
ALLO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.